{"license":"https://creativecommons.org/licenses/by/4.0/","dataset":"atlas","updatedThrough":"2026-08-15","guardrail":"The atlas exposes only relationships declared in the current public data. A link or issue grouping does not make unlike measures comparable, establish ownership or control, define an antitrust market, assign liability, or show that a policy event caused an economic outcome.","filters":{"depth":2,"edgeType":"all","edgeTypeMatched":true,"focus":"policy_entity:pent-humana-pharmacy-solutions","focusMatched":true,"kind":"all","kindMatched":true,"layer":"enforcement","layerMatched":true,"query":"","view":"network"},"summary":{"nodeCount":5478,"edgeCount":19193,"sourceCount":45,"profileCount":5433,"nodeKindCount":13,"layerCount":4,"eligibleEdgeCount":63,"matchedNodeCount":9,"plottedEdgeCount":8,"plottedNodeCount":9,"hiddenNodeCount":0,"directNeighborCount":1},"focusNode":{"id":"policy_entity:pent-humana-pharmacy-solutions","kind":"policy_entity","label":"Humana Pharmacy Solutions, Inc.","shortLabel":"Humana Pharmacy Solu...","description":"Pharmacy benefit manager named as a recipient of an FTC Section 6(b) order discussed in the interim staff report.","href":"/enforcement/entities/humana-pharmacy-solutions-inc","metricLabel":"Named records","metricValue":"1","detail":"Official-record organization label","status":"record-only label","year":null,"color":"#ec4899","searchText":"humana pharmacy solutions, inc. pharmacy benefit manager named as a recipient of an ftc section 6(b) order discussed in the interim staff report. report_subject","connectionCount":1},"nodes":[{"id":"policy_entity:pent-humana-pharmacy-solutions","kind":"policy_entity","label":"Humana Pharmacy Solutions, Inc.","shortLabel":"Humana Pharmacy Solu...","description":"Pharmacy benefit manager named as a recipient of an FTC Section 6(b) order discussed in the interim staff report.","href":"/enforcement/entities/humana-pharmacy-solutions-inc","metricLabel":"Named records","metricValue":"1","detail":"Official-record organization label","status":"record-only label","year":null,"color":"#ec4899","searchText":"humana pharmacy solutions, inc. pharmacy benefit manager named as a recipient of an ftc section 6(b) order discussed in the interim staff report. report_subject","connectionCount":1,"distance":0,"labelVisible":true,"radius":20,"x":450,"y":260},{"id":"policy_record:evt-pbm-interim-report-2024","kind":"policy_record","label":"FTC releases interim staff report on prescription drug middlemen","shortLabel":"FTC releases interim sta...","description":"The FTC published interim findings on PBM concentration and vertical integration, including aggregate shares for the largest PBMs.","href":"/enforcement/records/pbm-interim-report-2024","metricLabel":"Official stage","metricValue":"monitoring","detail":"Federal Trade Commission / 2024-07-09","status":"report","year":2024,"color":"#f43f5e","searchText":"evt-pbm-interim-report-2024 ftc releases interim staff report on prescription drug middlemen federal trade commission report monitoring the ftc published interim findings on pbm concentration and vertical integration, including aggregate shares for the largest pbms.","connectionCount":8,"x":450,"y":112,"distance":1,"radius":11,"labelVisible":true},{"id":"market:mkt-pbm","kind":"market","label":"U.S. pharmacy benefit management","shortLabel":"PBMs","description":"Pharmacy benefit management services profile based on FTC public findings. The FTC reports top-three and top-six aggregate shares but not enough individual PBM market shares in the public press-release record to compute HHI.","href":"/markets/us-pharmacy-benefit-management","metricLabel":"HHI status","metricValue":"Withheld","detail":"United States / 2023","status":"incomplete","year":2023,"color":"#14b8a6","searchText":"u.s. pharmacy benefit management pbms health care united states pharmacy benefit management services profile based on ftc public findings. the ftc reports top-three and top-six aggregate shares but not enough individual pbm market shares in the public press-release record to compute hhi.","connectionCount":10,"x":471.391,"y":22.963,"distance":2,"radius":8,"labelVisible":false},{"id":"policy_entity:pent-caremark-rx","kind":"policy_entity","label":"Caremark Rx, LLC","shortLabel":"Caremark Rx, LLC","description":"Pharmacy benefit manager named in FTC study and administrative complaint records.","href":"/enforcement/entities/caremark-rx-llc","metricLabel":"Named records","metricValue":"3","detail":"Official-record organization label","status":"record-only label","year":null,"color":"#ec4899","searchText":"caremark rx, llc pharmacy benefit manager named in ftc study and administrative complaint records. report_subject respondent remedy_subject","connectionCount":3,"x":648.66,"y":128.934,"distance":2,"radius":8,"labelVisible":false},{"id":"policy_entity:pent-express-scripts","kind":"policy_entity","label":"Express Scripts, Inc.","shortLabel":"Express Scripts, Inc.","description":"Pharmacy benefit manager named in FTC study and administrative complaint records.","href":"/enforcement/entities/express-scripts-inc","metricLabel":"Named records","metricValue":"3","detail":"Official-record organization label","status":"record-only label","year":null,"color":"#ec4899","searchText":"express scripts, inc. pharmacy benefit manager named in ftc study and administrative complaint records. report_subject respondent remedy_subject","connectionCount":3,"x":676.334,"y":333.6,"distance":2,"radius":8,"labelVisible":false},{"id":"policy_entity:pent-optumrx","kind":"policy_entity","label":"OptumRx, Inc.","shortLabel":"OptumRx, Inc.","description":"Pharmacy benefit manager named in FTC study and administrative complaint records.","href":"/enforcement/entities/optumrx-inc","metricLabel":"Named records","metricValue":"2","detail":"Official-record organization label","status":"record-only label","year":null,"color":"#ec4899","searchText":"optumrx, inc. pharmacy benefit manager named in ftc study and administrative complaint records. report_subject respondent","connectionCount":2,"x":533.574,"y":482.844,"distance":2,"radius":8,"labelVisible":false},{"id":"policy_entity:pent-medimpact","kind":"policy_entity","label":"MedImpact Healthcare Systems, Inc.","shortLabel":"MedImpact Healthcare...","description":"Pharmacy benefit manager named as a recipient of an FTC Section 6(b) order discussed in the interim staff report.","href":"/enforcement/entities/medimpact-healthcare-systems-inc","metricLabel":"Named records","metricValue":"1","detail":"Official-record organization label","status":"record-only label","year":null,"color":"#ec4899","searchText":"medimpact healthcare systems, inc. pharmacy benefit manager named as a recipient of an ftc section 6(b) order discussed in the interim staff report. report_subject","connectionCount":1,"x":327.881,"y":464.281,"distance":2,"radius":8,"labelVisible":false},{"id":"policy_entity:pent-prime-therapeutics","kind":"policy_entity","label":"Prime Therapeutics LLC","shortLabel":"Prime Therapeutics LLC","description":"Pharmacy benefit manager named as a recipient of an FTC Section 6(b) order discussed in the interim staff report.","href":"/enforcement/entities/prime-therapeutics-llc","metricLabel":"Named records","metricValue":"1","detail":"Official-record organization label","status":"record-only label","year":null,"color":"#ec4899","searchText":"prime therapeutics llc pharmacy benefit manager named as a recipient of an ftc section 6(b) order discussed in the interim staff report. report_subject","connectionCount":1,"x":214.146,"y":291.891,"distance":2,"radius":8,"labelVisible":false},{"id":"source:ftc-pbm-interim-2024","kind":"source","label":"Pharmacy Benefit Managers: The Powerful Middlemen Inflating Drug Costs and Squeezing Main Street Pharmacies","shortLabel":"Federal Trade Commission","description":"FTC interim staff report and press release on PBM concentration and vertical integration.","href":"/sources/ftc-pbm-interim-2024","metricLabel":"Access date","metricValue":"2026-05-16","detail":"Federal Trade Commission","status":"agency report","year":2026,"color":"#64748b","searchText":"ftc-pbm-interim-2024 pharmacy benefit managers: the powerful middlemen inflating drug costs and squeezing main street pharmacies federal trade commission ftc interim staff report and press release on pbm concentration and vertical integration. federal trade commission, ftc releases interim staff report on prescription drug middlemen, july 9 2024. agency_report","connectionCount":4,"x":278.014,"y":95.486,"distance":2,"radius":8,"labelVisible":false}],"rows":[{"id":"named-in-record:peel-caremark-report","layer":"enforcement","relationshipType":"named_in_record","relationshipLabel":"report subject","fromId":"policy_record:evt-pbm-interim-report-2024","fromKind":"policy_record","fromLabel":"FTC releases interim staff report on prescription drug middlemen","fromHref":"/enforcement/records/pbm-interim-report-2024","toId":"policy_entity:pent-caremark-rx","toKind":"policy_entity","toLabel":"Caremark Rx, LLC","toHref":"/enforcement/entities/caremark-rx-llc","evidenceLabel":"Exact official-record relationship","evidenceDetail":"The FTC interim report identifies Caremark Rx among the six PBMs that received Section 6(b) orders.","sourceId":"ftc-pbm-interim-2024","sourceUrl":"https://www.ftc.gov/news-events/news/press-releases/2024/07/ftc-releases-interim-staff-report-prescription-drug-middlemen","confidenceLevel":"bounded","indicatorId":null,"entityCode":null,"observationCount":null,"firstYear":null,"latestYear":null,"preferredView":null,"sourceIds":null,"guardrail":"A named-organization edge records the role encoded from one official record; it is not an independent liability or identity finding."},{"id":"named-in-record:peel-express-scripts-report","layer":"enforcement","relationshipType":"named_in_record","relationshipLabel":"report subject","fromId":"policy_record:evt-pbm-interim-report-2024","fromKind":"policy_record","fromLabel":"FTC releases interim staff report on prescription drug middlemen","fromHref":"/enforcement/records/pbm-interim-report-2024","toId":"policy_entity:pent-express-scripts","toKind":"policy_entity","toLabel":"Express Scripts, Inc.","toHref":"/enforcement/entities/express-scripts-inc","evidenceLabel":"Exact official-record relationship","evidenceDetail":"The FTC interim report identifies Express Scripts among the six PBMs that received Section 6(b) orders.","sourceId":"ftc-pbm-interim-2024","sourceUrl":"https://www.ftc.gov/news-events/news/press-releases/2024/07/ftc-releases-interim-staff-report-prescription-drug-middlemen","confidenceLevel":"bounded","indicatorId":null,"entityCode":null,"observationCount":null,"firstYear":null,"latestYear":null,"preferredView":null,"sourceIds":null,"guardrail":"A named-organization edge records the role encoded from one official record; it is not an independent liability or identity finding."},{"id":"named-in-record:peel-humana-report","layer":"enforcement","relationshipType":"named_in_record","relationshipLabel":"report subject","fromId":"policy_record:evt-pbm-interim-report-2024","fromKind":"policy_record","fromLabel":"FTC releases interim staff report on prescription drug middlemen","fromHref":"/enforcement/records/pbm-interim-report-2024","toId":"policy_entity:pent-humana-pharmacy-solutions","toKind":"policy_entity","toLabel":"Humana Pharmacy Solutions, Inc.","toHref":"/enforcement/entities/humana-pharmacy-solutions-inc","evidenceLabel":"Exact official-record relationship","evidenceDetail":"The FTC interim report identifies Humana Pharmacy Solutions among the six PBMs that received Section 6(b) orders.","sourceId":"ftc-pbm-interim-2024","sourceUrl":"https://www.ftc.gov/news-events/news/press-releases/2024/07/ftc-releases-interim-staff-report-prescription-drug-middlemen","confidenceLevel":"bounded","indicatorId":null,"entityCode":null,"observationCount":null,"firstYear":null,"latestYear":null,"preferredView":null,"sourceIds":null,"guardrail":"A named-organization edge records the role encoded from one official record; it is not an independent liability or identity finding."},{"id":"named-in-record:peel-medimpact-report","layer":"enforcement","relationshipType":"named_in_record","relationshipLabel":"report subject","fromId":"policy_record:evt-pbm-interim-report-2024","fromKind":"policy_record","fromLabel":"FTC releases interim staff report on prescription drug middlemen","fromHref":"/enforcement/records/pbm-interim-report-2024","toId":"policy_entity:pent-medimpact","toKind":"policy_entity","toLabel":"MedImpact Healthcare Systems, Inc.","toHref":"/enforcement/entities/medimpact-healthcare-systems-inc","evidenceLabel":"Exact official-record relationship","evidenceDetail":"The FTC interim report identifies MedImpact among the six PBMs that received Section 6(b) orders.","sourceId":"ftc-pbm-interim-2024","sourceUrl":"https://www.ftc.gov/news-events/news/press-releases/2024/07/ftc-releases-interim-staff-report-prescription-drug-middlemen","confidenceLevel":"bounded","indicatorId":null,"entityCode":null,"observationCount":null,"firstYear":null,"latestYear":null,"preferredView":null,"sourceIds":null,"guardrail":"A named-organization edge records the role encoded from one official record; it is not an independent liability or identity finding."},{"id":"named-in-record:peel-optumrx-report","layer":"enforcement","relationshipType":"named_in_record","relationshipLabel":"report subject","fromId":"policy_record:evt-pbm-interim-report-2024","fromKind":"policy_record","fromLabel":"FTC releases interim staff report on prescription drug middlemen","fromHref":"/enforcement/records/pbm-interim-report-2024","toId":"policy_entity:pent-optumrx","toKind":"policy_entity","toLabel":"OptumRx, Inc.","toHref":"/enforcement/entities/optumrx-inc","evidenceLabel":"Exact official-record relationship","evidenceDetail":"The FTC interim report identifies OptumRx among the six PBMs that received Section 6(b) orders.","sourceId":"ftc-pbm-interim-2024","sourceUrl":"https://www.ftc.gov/news-events/news/press-releases/2024/07/ftc-releases-interim-staff-report-prescription-drug-middlemen","confidenceLevel":"bounded","indicatorId":null,"entityCode":null,"observationCount":null,"firstYear":null,"latestYear":null,"preferredView":null,"sourceIds":null,"guardrail":"A named-organization edge records the role encoded from one official record; it is not an independent liability or identity finding."},{"id":"named-in-record:peel-prime-report","layer":"enforcement","relationshipType":"named_in_record","relationshipLabel":"report subject","fromId":"policy_record:evt-pbm-interim-report-2024","fromKind":"policy_record","fromLabel":"FTC releases interim staff report on prescription drug middlemen","fromHref":"/enforcement/records/pbm-interim-report-2024","toId":"policy_entity:pent-prime-therapeutics","toKind":"policy_entity","toLabel":"Prime Therapeutics LLC","toHref":"/enforcement/entities/prime-therapeutics-llc","evidenceLabel":"Exact official-record relationship","evidenceDetail":"The FTC interim report identifies Prime Therapeutics among the six PBMs that received Section 6(b) orders.","sourceId":"ftc-pbm-interim-2024","sourceUrl":"https://www.ftc.gov/news-events/news/press-releases/2024/07/ftc-releases-interim-staff-report-prescription-drug-middlemen","confidenceLevel":"bounded","indicatorId":null,"entityCode":null,"observationCount":null,"firstYear":null,"latestYear":null,"preferredView":null,"sourceIds":null,"guardrail":"A named-organization edge records the role encoded from one official record; it is not an independent liability or identity finding."},{"id":"policy-scope:evt-pbm-interim-report-2024:mkt-pbm","layer":"enforcement","relationshipType":"policy_scope","relationshipLabel":"Related policy context","fromId":"market:mkt-pbm","fromKind":"market","fromLabel":"U.S. pharmacy benefit management","fromHref":"/markets/us-pharmacy-benefit-management","toId":"policy_record:evt-pbm-interim-report-2024","toKind":"policy_record","toLabel":"FTC releases interim staff report on prescription drug middlemen","toHref":"/enforcement/records/pbm-interim-report-2024","evidenceLabel":"Federal Trade Commission / 2024-07-09","evidenceDetail":"Supplies top-three and top-six concentration facts while leaving individual firm shares unavailable; Antitrust Radar therefore continues to withhold HHI.","sourceId":"ftc-pbm-interim-2024","sourceUrl":"https://www.ftc.gov/news-events/news/press-releases/2024/07/ftc-releases-interim-staff-report-prescription-drug-middlemen","confidenceLevel":"bounded","indicatorId":null,"entityCode":null,"observationCount":null,"firstYear":null,"latestYear":null,"preferredView":null,"sourceIds":null,"guardrail":"A related-market edge records the observatory's bounded context for a dated official event; it does not show causal effects on concentration."},{"id":"record-source:evt-pbm-interim-report-2024:ftc-pbm-interim-2024","layer":"enforcement","relationshipType":"record_source","relationshipLabel":"Official record source","fromId":"policy_record:evt-pbm-interim-report-2024","fromKind":"policy_record","fromLabel":"FTC releases interim staff report on prescription drug middlemen","fromHref":"/enforcement/records/pbm-interim-report-2024","toId":"source:ftc-pbm-interim-2024","toKind":"source","toLabel":"Pharmacy Benefit Managers: The Powerful Middlemen Inflating Drug Costs and Squeezing Main Street Pharmacies","toHref":"/sources/ftc-pbm-interim-2024","evidenceLabel":"Federal Trade Commission","evidenceDetail":"Pharmacy Benefit Managers: The Powerful Middlemen Inflating Drug Costs and Squeezing Main Street Pharmacies is the custody record encoded for this dated policy event.","sourceId":"ftc-pbm-interim-2024","sourceUrl":"https://www.ftc.gov/news-events/news/press-releases/2024/07/ftc-releases-interim-staff-report-prescription-drug-middlemen","confidenceLevel":"high","indicatorId":null,"entityCode":null,"observationCount":null,"firstYear":null,"latestYear":null,"preferredView":null,"sourceIds":null,"guardrail":"The source is the official custody record for the encoded event; later outcomes require separate evidence."}]}